Antimicrobial Stewardship & Healthcare Epidemiology (Jan 2022)

Three-day ceftriaxone versus longer durations of therapy for inpatient treatment of uncomplicated urinary tract infection

  • Balsam Elajouz,
  • Lisa E. Dumkow,
  • Lacy J. Worden,
  • Kali M. VanLangen,
  • Andrew P. Jameson

DOI
https://doi.org/10.1017/ash.2022.317
Journal volume & issue
Vol. 2

Abstract

Read online

Current guidelines do not address a recommended duration of parenteral therapy for uncomplicated urinary tract infection (uUTI) treatment in the inpatient setting. We compared a 3-day course of ceftriaxone with longer antibiotic durations for inpatients with a uUTI. Our findings indicate that a 3-day course of ceftriaxone was as efficacious as longer antibiotic courses.